Excalibur Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Buy
+2,390
New +$213K 0.07% 155
2025
Q4
Sell
-2,520
Closed -$201K 163
2025
Q3
$201K Hold
2,520
0.07% 161
2025
Q2
$229K Sell
2,520
-10
-0.4% -$913 0.09% 154
2025
Q1
$237K Hold
2,530
0.09% 149
2024
Q4
$230K Sell
2,530
-25
-1% -$2.39K 0.09% 152
2024
Q3
$265K Sell
2,555
-50
-2% -$5.1K 0.1% 145
2024
Q2
$253K Sell
2,605
-50
-2% -$4.61K 0.1% 143
2024
Q1
$239K Buy
2,655
+40
+2% +$3.39K 0.1% 144
2023
Q4
$208K Buy
+2,615
New +$197K 0.1% 150
2022
Q3
Sell
-2,560
Closed -$205K 151
2022
Q2
$205K Buy
+2,560
New +$200K 0.11% 142
2022
Q1
Sell
-2,678
Closed -$229K 156
2021
Q4
$229K Hold
2,678
0.09% 148
2021
Q3
$202K Hold
2,678
0.09% 151
2021
Q2
$218K Buy
2,678
+38
+1% +$3.11K 0.1% 149
2021
Q1
$208K Sell
2,640
-25
-0.9% -$1.96K 0.1% 145
2020
Q4
$228K Sell
2,665
-25
-0.9% -$2.07K 0.12% 132
2020
Q3
$208K Buy
+2,690
New +$205K 0.13% 122

Other funds holding CL

Excalibur Management's CL Position: Q1 2026 in Review

Excalibur Management opened a new position in Colgate-Palmolive (CL) in Q1 2026: 2,390 shares worth $204K. The stake represents 0.07% of the portfolio and ranks #155 among its holdings. This is a return to the name: Excalibur Management previously reported a position in CL as recently as Q3 2025.

Excalibur Management first reported a position in CL in Q3 2020 and has held it in 16 quarters since. The position peaked at $265K in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Excalibur Management held 2,390 shares of Colgate-Palmolive worth $204K as of Q1 2026.
  • Colgate-Palmolive was a new Excalibur Management position in Q1 2026.
  • Colgate-Palmolive made up 0.07% of Excalibur Management's portfolio in Q1 2026, its #155 holding.
  • Excalibur Management first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 16 quarters since.
  • Excalibur Management's Colgate-Palmolive position peaked at $265K in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Excalibur Management's 13F filing for Q1 2026, filed 5 May 2026.